Clinical Trial Update: A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis [NA]

View source ↗

Summary

A pilot clinical trial evaluates the therapeutic efficacy of intra-lesional immunotherapy for recalcitrant tinea corporis and tinea cruris in patients aged 10-6…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis
• Tinea Cruris

Drugs mentioned

• Intra-lesional immunotherapy

Snippet

Sponsor: Abeer Mohamed Abdelaziz Elkholy | Conditions: Tinea Corporis, Tinea Cruris | NA | Status: RECRUITING